cmAngio® vs cvi42 Auto Imaging
AI Verdict
Choose cmAngio® if…
Choose cmAngio® if your primary objective is to integrate AI-powered detection of Breast Arterial Calcifications (BAC) into routine mammography screenings. This tool is ideal for leveraging existing breast imaging workflows to non-invasively assess a woman's cardiovascular risk, providing early insights into cardiovascular health without requiring additional radiation or procedures.
View cmAngio® →Choose cvi42 Auto Imaging if…
Choose cvi42 Auto Imaging if your clinical practice demands comprehensive, AI-powered quantitative analysis of advanced cardiovascular MR and CT images. This software is best suited for cardiologists and radiologists needing detailed diagnostic insights into cardiac function, flow, tissue characterization, and precise plaque quantification across multiple modalities for complex cardiovascular disease assessment and treatment planning.
View cvi42 Auto Imaging →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | cvi42 Auto Imaging |
|---|---|---|
| Pricing | Paid, out-of-pocket | Starts at $5000 per license |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | On-premise (standalone workstation or client/server) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
cvi42 Auto ImagingTool A emphasizes quick installation and compatibility with any DICOM viewer, suggesting ease of initial adoption. However, Tool B provides a consistent workspace across multiple complex modalities (MR, CT, structural heart, EP) with AI-driven workflows and seamless integration with enterprise systems like PACS and reporting tools, offering a more comprehensive and streamlined user experience for advanced cardiovascular imaging workflows.
Clinical Value
cvi42 Auto ImagingTool A offers significant value by repurposing mammograms for early cardiovascular risk assessment through BAC detection, addressing an underreported finding. Tool B, however, provides comprehensive, multi-modality (MR, CT) quantitative analysis for precise diagnosis, plaque quantification, and treatment planning across a wider range of established cardiovascular conditions, directly impacting complex patient management.
Pricing & Value
cvi42 Auto ImagingWhile both require direct contact for pricing, Tool A mentions potential 'no-cost implementation and service' offers, which is attractive for initial adoption. Tool B, with its 'Elevate pricing structure' and flexible subscription model, is designed to scale across multiple CT and MR service lines, offering a more integrated and potentially cost-effective long-term solution for comprehensive cardiovascular imaging departments by aligning with volume and growth.
Enterprise Readiness
cvi42 Auto ImagingTool A is HIPAA-compliant, cybersecure, and compatible with DICOM viewers, with inferred cloud deployment. Tool B demonstrates robust enterprise readiness through explicit 'Enterprise-Class Interoperability' with unified authentication, simplified integrations for PACS/VNA, EMR, DICOM, and HL7, and a 'streamlined support' model, further supported by its widespread adoption in major hospitals globally.
Innovation
cmAngio®Tool A presents a highly innovative approach by leveraging AI to detect Breast Arterial Calcifications (BAC) on routine mammograms, effectively transforming a breast cancer screening into a dual-purpose exam for cardiovascular risk assessment without additional procedures or radiation. This repurposes existing data for a novel clinical insight in a different disease domain.
Support & Docs
cvi42 Auto ImagingTool A's information on support and documentation is limited to a website contact. Tool B explicitly details a 'world class support' team, global availability in multiple languages and time zones, and boasts high customer satisfaction scores (98% CSAT, 69 NPS), along with offering help guides, webinars, and on-site training.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | cvi42 Auto Imaging |
|---|---|---|
| Name | cmAngio® | cvi42 Auto Imaging |
| Company | CureMetrix | Circle Cardiovascular Imaging Inc. |
| Description | FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. | AI-powered software for comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows. |
| Key Features | AI-based detection of Breast Arterial Calcifications (BAC); Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams; Provides visualization of BAC location on a scorecard; Enables BAC identification and reporting without additional radiation or procedures; Compatible with any DICOM-compliant viewer; Adjustable operating point to meet clinical goals; Quick and easy installation (less than an hour); Cybersecure and HIPAA-compliant | AI-enabled automated contouring and segmentation; Cardiac MR analysis (Function, Flow, Tissue Characterization, Strain); Cardiac CT analysis (Calcium Scoring, Coronary Arteries, Plaque Assessment); Vascular CT analysis (diagnosis, planning, surveillance); Quantitative analysis (volume, mass, function, signal intensity, plaque); 3D visualization and multiplanar reconstruction (MPR); Simplified and smart reporting with infographics and CAD-RADS classification; Multi-modality support (MR, CT) and vendor-neutral compatibility |
| Data Export | FHIR JSON | DICOM Secondary Capture, DICOM encapsulated PDF, PDF, text |
| Target Customer Size | Hospitals, imaging centers, and health systems of varying sizes, including small and midsized imaging centers and hospitals. | Hospitals, clinics, and imaging centers. |
| Customer Count | 400+ | Over 1,700 hospitals in more than 90 countries. |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and cvi42 Auto Imaging.